| Literature DB >> 25610575 |
Mohammad Arjmand1, Abdolah Mirzaei2, Mohammad Reza Jafarzadeh Shirazi1, Amin Tamadon3, Mohammad Saied Salehi1, Mehdi Saeb4, Mohammad Reza Namavar5, Mohammad Reza Zandi1, Hojatollah Shahheidari1, Sara Moradi1.
Abstract
The aims of the present study were to evaluate luteal activity in Abadeh ecotype goat during summer and winter and also the effect of a single dose kisspeptin-10 injection on the secretion of luteinizing hormone (LH) in female anestrous goats. In the first study, progesterone (P4) concentration in 10 goats in summer (n = 6) and winter (n = 4) were measured every other day. Moreover, in summer group, a male teaser goat was left in the herd on days of sampling for one hour. Goats with P4 concentration ≥1 ng mL(-1), at least two consecutive measurements, were considered with luteal activity. In the second study, the anestrous phase was confirmed by P4 measurement 20 and 10 days before the kisspeptin injection in five female Abadeh ecotype goats (4 to 5 years old). The goats were given a single IV injection of saline (2 mL) as control group and the same goats (1 hr after the last blood sampling) were given kisspeptin (1 μg kg(-1)) as treatment group. The blood samples were collected at -60, -40, -20 and 0 min (before injection), and 10, 20, 30, 40, 50, 60, 80, 100, 120 and 140 min after the injection and LH concentration were measured. A single IV injection of 1 µg kg(-1) of kisspeptin-10 did not stimulate the release of LH in female anestrous goats. In summer, in the presence of teaser goat, luteal activity was seen in all goats. In the absence of male goat in winter, some goats showed luteal activity and others showed anestrus.Entities:
Keywords: Anestrus; Goat; Kisspeptin; Luteal activity; Luteinizing hormone
Year: 2014 PMID: 25610575 PMCID: PMC4299989
Source DB: PubMed Journal: Vet Res Forum ISSN: 2008-8140 Impact factor: 1.054
Literature review of the effect of different types of Kisspeptin administration on the LH release in mammalian species
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Cow | Female | Cycling | Kisspeptin-10 | IV | 100 or 200 pmol kg-1 | 23 |
| Human | Male | Adult | Kisspeptin-54 | IV | 4 pmol kg-1 per min, 90-min | 27 |
| Human | Male | Adult | Kisspeptin-10 | IV | 0.01-3.0 μg kg-1 | 46 |
| Human | Female | Menstrual cycle | Kisspeptin-54 | SC | 0.4 nmol kg-1 | 28 |
| Human | Female | Hypothalamic amenorrhea | Kisspeptin-54 | SC | 6.4 nmol kg-1 twice daily for 2 week | 4 7 |
| Mouse | Male | Adult | Kisspeptin-10 | ICV | 1 fmol | 15 |
| Mouse | Male | Adult | Mouse kisspeptin 105-119 | IP | 100 μl of 10 μM | 19 |
| Rat | Male and female | Adult | Rodent kisspeptin-10 | ICV | 1 nmol | 4 8 |
| Rat | Male | Adult | Kisspeptin-10 | ICV/Peripheral | 3 nmol | 49 |
| Rat | Male | Adult | Kisspeptin-54 | ICV | 1, 10 or 100 pmol | 50 |
| Rat | Male | Adult | Rat kisspeptin-52 | ICV | 0.1 nmol | 51 |
| Rat | Male | Adult | Rat kisspeptin-10 | ICV | 1 nmol | 51 |
| Rat | Male | Adult | Rat kisspeptin-52 | IV | 10 nmol kg-1 | 51 |
| Rat | Male | Adult | Kisspeptin-10 | IV | 0.3 nmol kg-1 | 24 |
| Rat | Male | Pre-puberty | Metastin | SC | 100 nmol kg-1 (male) | 52 |
| Rat | Female | Cyclic, pregnant and lactating | Kisspeptin-10 | ICV | 0.1 pmol - 1 nmol | 53 |
| Monkey | Male | Agonadal juvenile | Human kisspeptin 45-54 | 10 μg | 45 | |
| Monkey | Male | Adult | Human kisspeptin 45-54 | IV | 200 or 400 μg per hr | 54 |
| Monkey | Male | Agonadal juvenile | Kisspeptin-10 | ICV/IV | 30 μg or 100 μg | 26 |
| Pig | Male and female | Pre-puberty | Murine kisspeptin | ICV/Peripheral | 10 or 100 μg | 25 |
| Sheep | Female | Estradiol-treated ovariectomized | Human kisspeptin 112-121 | ICV | 0.2 μg per min for 4 hr | 19 |
| Sheep | Female | Estradiol-treated ovariectomized | Human kisspeptin-1 | IV | 6 nmol | 21 |
| Sheep | Female | Anestrous season | Murine kisspeptin-10 | IV | 12.4 nmol per hr, for 30 or 48 hr | 21 |
| Sheep | Female | Breeding season | Murine kisspeptin-10 | IV | 0.48 μmol per hr over 8 hr | 21 |
| Sheep | Female | Anestrous season | Kisspeptin-10 | IV | 15.2 nmol per hr | 43 |
| Goat | Male | Adult | Kisspeptin-10 | IV | 5 µg kg-1 | 42 |
| Goat | Female | Luteal phase | Kisspeptin-10 | IV | 1, 5 and 10 μg kg-1 | 41 |
| Welsh pony | Female | Cycling | Human kisspeptin-10 | IV | 10 mg | 55 |
| Cow | Female | Pre-puberty | Kisspeptin-10 | IV | 1 mg | 22 |
| Cow | Male and female | Pre-puberty | Kisspeptin-10 | IV or IM | 5 μg kg-1 | 56 |
SC: Subcutaneous; IV: Intravenous; IP: Intraperitoneal; IM: Intramuscular.
ICV: Intracerebroventricular;
Fig. 1Patterns of serum progesterone concentration in six Abadeh ecotype goats in summer (non-breeding season). Samplings were done an hour after the presence of teaser buck. a) normal luteal activity; b) normal luteal activity and short luteal phase; c) short luteal phase and normal luteal activity; d and e) end of anestrus and beginning of luteal activity and f) end of luteal activity and beginning of anestrus. Stars show the time of heat detection.
Fig. 2Patterns of serum progesterone concentration in four Abadeh ecotype goats in winter (breeding season) in the absence of teaser buck during the sampling days. a) Normal luteal activity; b) short luteal phase; c and d) anestrus
Fig. 3The serum luteinizing hormone concentration (LH, ng mL-1) in response to intravenous injections of 1 μg kg-1 body weight of kisspeptin (treatment) or saline (control) in anestrous does (Abadeh ecotype goats). Arrow indicates the time of injection. Each value represents the mean ± SEM for five animals